Lumen Technologies, Inc. (LUMN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed Lumen Technologies, Inc. (“Lumen” or the “Company”) (NYSE: LUMN) f
DOCN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DigitalOcean Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DigitalOcean Holdings, Inc. (“DigitalOcean” or “the Company”
IART INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Integra LifeSciences Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Attorney Advertising, Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Integra LifeSciences Holdings Corporation (“Integra” or “the CompanyR
Demand for Sustainable Raw Materials Could Exceed Supply by as Much as 133 Million Tons by 2030
New Report from BCG, Textile Exchange, and Quantis Finds That Fashion and Apparel Brands Can Seize an Average 6% Net Profit Increase by Closing the Raw-Materials Gap LONDON, Oct. 25, 2023 /PRNewswire/ — The fashion and apparel industry is under pressure. More than 85% of leading brands (by sa
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDD Holdings Inc. – PDD
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of PDD Holdings Inc. (“PDD” or the “Company”) (NASDAQ: PDD). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
Bridge Biotherapeutics Announces Positive Recommendation from the Independent Data Monitoring Committee of the BBT-877 Phase 2a Study in Idiopathic Pulmonary Fibrosis
The independent data monitoring committee (IDMC) recommended the continuation of the BBT-877 Phase 2a trial based on the initial clinical data from the first 20 participants dosed with the investigational productNo safety concerns were raised based on the evaluation of the data presented at the IDMC
Qatar Elevators and Escalators Market Report 2023-2029: Investment-Friendly Policies Attract Foreign Property Investments, Infrastructure Projects within Qatar National Vision 2030 Drives Growth
DUBLIN, Oct. 25, 2023 /PRNewswire/ — The “Qatar Elevators and Escalators Market – Size & Growth Forecast 2023-2029” report has been added to ResearchAndMarkets.com’s offering. The Qatar elevator and escalator market is expected to account for 973,000 units by 202
Tree Nuts Market to grow by USD 20.01 billion from 2022 to 2027, The market share growth of the almonds segment will be significant during the forecast period. – Technavio
NEW YORK, Oct. 25, 2023 /PRNewswire/ — The tree nuts market is expected to grow by USD 20.01 billion from 2022 to 2027, according to Technavio. In addition, the growth momentum of the market will progress at a CAGR of 7.15% during the forecast period. The rising popularity of vegan snacks amo
SK hynix Reports Third Quarter 2023 Financial Results
– Technical prowess, competitive products help expand revenues, narrow operating losses– DRAM turns around from two quarters of losses, helped by brisk sales of premium products– “Company to open up new markets with advanced technology as key player of future AI infrastructur
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of The Boeing Company – BA
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Boeing Company (“Boeing” or the “Company”) (NYSE: BA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
